Factor x leicester: Ile411Phe associated with a low antigen level and a disproportionately low functional activity of factor X

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 3, 2003, Pages 603-605

  Deam, S ^a   Uprichard, J ^b   Eaton, J T ^c   Perkins, S J ^c   Dolan, G ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10;

AMINO ACID SUBSTITUTION; BLOOD CLOTTING FACTOR 10 DEFICIENCY; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; HUMAN; LETTER; MUTATION; PROTEIN CONFORMATION;

AMINO ACID SUBSTITUTION; FACTOR X; FACTOR X DEFICIENCY; HUMANS; MODELS, MOLECULAR; MUTATION; PROTEIN CONFORMATION;

EID: 0642311170     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.t01-3-00177.x     Document Type: Letter

References (14)

1. Perry DJ. Factor X and its deficiency states. Haemophilia 1997; 3: 159-72.
2. Jagadeaswaran P, Reddy SV, Rao KJ, Hamsabhushanam K, Lyman G. Cloning and characterisation of the 50 end (exon 1) of the gene encoding human factor X, a blood coagulation factor. Gene 1989; 84: 517-9.
3. Deam S, Srinivasan N, Westby J, Horn EH, Dolan G. FX Nottingham and FX Taunton: two novel mutations resulting in loss of functional activity and an interpretation using molecular modelling. Thromb Haemost 2001; 85: 265-9.
4. Peyvandi F, Menegatti M, Santagostino E, Akhavan S, Uprichard J, Perry DJ, Perkins SJ, Mannucci PM. Gene mutations and three-dimensional structural analysis in 13 families with severe Factor X deficiency. Br J Haematol 2002; 117: 685-292.
5. Jenkins PV, Pasi KJ, Perkins SJ. Molecular modelling of ligand and mutation sites of the Type A domains of human von Willebrand factor and their relevance to von Willebrand's disease. Blood 1998; 91: 2032-44.
6. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucl Acids Res 1997; 25: 3389-402.
7. Higgins DG, Bleasby AJ, Fuchs R. CLUSTALV: improved software for multiple sequence alignment. Comput Appl Biosci 1992; 8: 189-91.
8. Kamata K, Kawamoto H, Honma T, Iwama T, Kim SH. Structural basis for chemical inhibition of human blood coagulation factor Xa. Proc Natl Acad Sci USA 1998; 95: 6630-5.
9. Bode W, Mayr I, Baumann U, Huber R, Stone SR, Hofsteenge J. The refined 1.9 A crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment. EMBO J 1989; 8: 3467-75.
10. KabschW, Sander C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 1983; 22: 2577-637.
11. Lee B, Richards FM. The interpretation of protein structures: estimation of static accessibility. J Molec Biol 1971; 55: 379-400.
12. Sali A, Blundell TL. The definition of topological equivalence in homologous and analogous structures: a procedure involving a comparison of local properties and relationships. J Molec Biol 1990; 212: 403-28.
13. 2+ site in the protease domain of human coagulation factor Xa. J Biol Chem 2000; 275: 36876-84.
14. + binding site of thrombin. Biophys Chem 1997; 63: 185-200